trial

Prevention Trial of Family Focused Treatment in Youth at Risk for Psychosis

NCTId NCT01907282
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Completed
Enrollment 129 (actual)
Sponsored by University of California Riverside at C.I. Trials, Inc.-Inland Empire
Primary completion 2013-01
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
129 (actual)
Study type
Interventional
Allocation
Randomized
Model
Factorial
Masking
Single
Start
2010-01
Primary completion
2013-01
Eligibility
ALL · 12 Years · 35 Years

Interventions & indications

Drugs
Family Focused TreatmentEnhanced Care

Sponsors

University of California Riverside at C.I. Trials, Inc.-Inland EmpireLead Sponsor
National Institute of Mental Health (NIMH)Collaborator

Investigators

2
David J Miklowitz, PhDPrincipal Investigator
Tyrone Cannon, Ph.D.Study Director

Sites

8 total
Los Angeles, United StatesSan Diego, United StatesNew Haven, United StatesAtlanta, United StatesBoston, United StatesNew York, United StatesChapel Hill, United StatesCalgary, Canada

Facts & assertions

4 sourced
Enrollment
129
Phase
NA
Primary Completion Date
2013-01
Status
COMPLETED
relationships
The graph out of here
drug
Family Focused Treatment
drug
Enhanced Care
drug
lead_sponsor
University of California Riverside at C.I. Trials, Inc.-Inland Empire
company
collaborator
National Institute of Mental Health (NIMH)
company
indication
Psychosis
indication
Schizophrenia
indication
Psychotic Disorders
indication
investigator
David J Miklowitz, PhD
person
Tyrone Cannon, Ph.D.
person